Navigation Links
Aratana Therapeutics to Present at Two Upcoming Healthcare Conferences
Date:2/5/2013

KANSAS CITY, Kan. and BOSTON, Feb. 5, 2013 /PRNewswire/ -- Aratana Therapeutics, a biopharmaceutical company developing innovative medicines for cats and dogs (companion animals), today announced that it will present at two upcoming healthcare conferences.  Steven St. Peter , M.D., President and Chief Executive Officer of Aratana Therapeutics, will provide an overview of the Company's business and will be available to participate in one-on-one meetings with potential collaborators. 

Aratana has been selected as one of a few privately held companies to present at the 2013 BIO CEO and Investor Conference, to be held February 11-12, 2013, at the Waldorf Astoria Hotel in New York.  Event:BIO CEO and Investor ConferenceDate: Tuesday, February 12, 2013 Time: 9:45 am (Eastern Time) Location:Park South; Waldorf Astoria Hotel; New YorkThe Company will also present at the Leerink Swann Global Healthcare Conference, to be held February 13-14, 2013, also at the Waldorf Astoria Hotel.  Event:Leerink Swann Global Healthcare ConferenceDate: Thursday, February 14, 2013 Time: 2:30 pm (Eastern Time) Location:Morgan Suite; Waldorf Astoria Hotel; New YorkDr. St. Peter will be joined by Louise Mawhinney , CPA, Chief Financial Officer; Linda Rhodes , V.M.D., Ph.D., Chief Scientific Officer; Julia Stephanus , Chief Commercial Officer; and Erick Lucera , Vice President, Corporate Development of Aratana Therapeutics.About Aratana TherapeuticsAratana Therapeutics is a biopharmaceutical company positioned to deliver high quality new medicines that address significant therapeutic needs for cats and dogs (companion animals).  Aratana licenses and develops proprietary, patent-protected compounds acquired from human pharmaceutical and biotechnology companies and then develops strategies to maximize the value of the programs for the animal health market.  For more information, please visit www.aratanatherapeutics.com.

For Investors & Media:
Joshua Drumm , Ph.D. / Andrew Mielach
Tiberend Strategic Advisors, Inc.
(212) 827-0020
jdrumm@tiberend.com 
amielach@tiberend.com


'/>"/>
SOURCE Aratana Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Aratana Closes $12 Million Series C Financing to Fund Pipeline Expansion
2. Aratana Therapeutics Appoints Erick Lucera Vice President of Corporate Development
3. Aratana to Present at Bank of America Merrill Lynch Animal Health Summit
4. Aratana to Participate in Leerink Swanns November Management Access Days
5. Novelos Therapeutics To Present At The 15th Annual BIO CEO & Investor Conference On February 11
6. Arno Therapeutics, Inc. Appoints Randy Thurman to the Board of Directors
7. Prime Therapeutics named a 2013 National Top Workplace
8. Novelos Therapeutics Presents Diapeutic Technology Platform At EMIT: Targeted Radiotherapy International Conference
9. Cell Therapeutics Announces Data Safety and Monitoring Board Recommendation to Continue the GOG-0212 Phase 3 Clinical Trial of OPAXIOTM as Maintenance Therapy in Ovarian Cancer
10. Inherited Orphan Blood Disorders Therapeutics Market to 2019 - Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet Need
11. Prime Therapeutics names Ann Tobin as Chief Compliance Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)... , Oct. 4, 2017 OBP ... self-contained, illuminating medical devices, today announced regulatory approval ... Surveillance Agency (or Agência Nacional de Vigilância Sanitária ... single-use, cordless surgical retractor with integrated LED light ... access, illumination and exposure of a tissue pocket ...
(Date:10/2/2017)... -- AllianceRx Walgreens Prime, the combined central specialty pharmacy and ... manager Prime Therapeutics LLC (Prime), today officially began the ... of new signage at its headquarters in ... few other company-owned facilities across the country. This also ... whom will begin to see the AllianceRx Walgreens Prime ...
(Date:9/28/2017)... Sept. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: ... conference call and webcast on Friday, November 3, 2017, ... and ending at approximately 8:30 a.m. (CDT) / 9:30 ... company,s 2017 financial performance and guidance for 2018, Hill-Rom ... to enhance operational performance, and long-range financial outlook through ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... , ... PurhealthRX , a leading Health and Nutrition Company, is announcing ... full spectrum CBD oil will revolutionize the rapidly growing CBD market by reducing the ... incorporated into liquid products, while reducing costs to end users. , The team of ...
(Date:10/13/2017)... ... 2017 , ... Lori R. Somekh, founder of the Law Office of ... elder law and special needs planning attorneys. “Membership in ElderCounsel helps our office remain ... to network with elder law attorneys nationwide,” said Somekh. , ElderCounsel ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term ... long-term care insurance companies have a waiver for care if the client has a ... when the family pays for care, is often waived, so the benefits from their ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for ... for action towards gender equality at their inaugural Summit in New York City in ... reached a social audience of over 3 million. To watch the Mobilize Women video, ...
(Date:10/13/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, ... and least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints ... for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says ...
Breaking Medicine News(10 mins):